✦ LIBER ✦

Clinical development of novel proteasome inhibitors for cancer treatment

✍ Scribed by Yang, Huanjie; Zonder, Jeffrey A; Dou, Q Ping

Book ID: 127327414
Publisher: Informa plc
Year: 2009
Tongue: English
Weight: 609 KB
Volume: 18
Category: Article
ISSN: 1354-3784
DOI: 10.1517/13543780903002074

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Proteasome inhibitors in the treatment o

Proteasome inhibitors in the treatment of cancer

✍ Jakub Golab 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 22 KB

CDK inhibitors in clinical development f

CDK inhibitors in clinical development for the treatment of cancer

✍ Fischer, Peter M; Gianella-Borradori, Athos 📂 Article 📅 2003 🏛 Informa plc 🌐 English ⚖ 450 KB

Clinical development of phosphatidylinos

Clinical development of phosphatidylinositol 3-kinase inhibitors for cancer treatment

✍ Irene Brana, Lillian L Siu 📂 Article 📅 2012 🏛 BioMed Central 🌐 English ⚖ 432 KB

Preclinical and clinical evaluation of p

Preclinical and clinical evaluation of proteasome inhibitor PS-341 for the treatment of cancer

✍ Julian Adams 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 824 KB

The proteasome is a multicatalytic protease, present in all eukaryotic cells, that is primarily responsible for intracellular protein degradation. By destroying regulatory proteins or their inhibitors, the proteasome influences many cellular regulatory signals and is thus a potential target for phar

ChemInform Abstract: The Development and

ChemInform Abstract: The Development and Pharmacology of Proteasome Inhibitors for the Management and Treatment of Cancer

✍ Bruce Ruggeri; Sheila Miknyoczki; Bruce Dorsey; Ai-Min Hui 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 15 KB

## Abstract Review: 155 refs.

Clinical development of aromatase inhibi

Clinical development of aromatase inhibitors for the treatment of breast and prostate cancer

✍ Dowsett, M. 📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 484 KB